We have had a few posts recently about the Exon 20 mutation, and what treatment is available for that. Last week the NHS approved a new drug called Mobocertinib tablets, which is being called a game changing drug for people with the Exon 20 mutation. This drug is being offered to 100 patients each year, and with a cost of £19,000 per month per patient, it is a reminder of how lucky we are to have our NHS.
I will put a link to the article below for anyone who wishes to read about this.
gail
